The 8-Year Retention Rate of the First TNF-Inhibitor in the Treatment of Spondyloarthropathies: Real-Life Data from Three Local Registries

被引：0
|
作者：
Favalli, Ennio Giulio [1 ]
Becciolini, Andrea [1 ]
Biggioggero, Martina [2 ]
Fusaro, Enrico [3 ]
Parisi, Simone [3 ]
Ariani, Alarico [4 ]
Santilli, Daniele [4 ]
Marchesoni, Antonio [1 ]
Meroni, Pier Luigi [2 ]
机构：
[1] Gaetano Pini Inst, Dept Rheumatol, Milan, Italy
[2] Univ Milan, Gaetano Pini Inst, Div Rheumatol, Dept Clin Sci & Community Hlth, Milan, Italy
[3] Citta Salute & Sci, Turin, Italy
[4] Univ Parma, Dept Internal Med & Rheumatol, I-43100 Parma, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2857
引用
收藏
页数：1
相关论文
共 38 条
  • [21] First real-life experiences with 2 mg bulevirtide for the treatment of hepatitis delta-data from a tertiary reference centre in Germany
    Zoellner, Caroline
    Lutz, Katrin
    Demir, Muenevver
    Tacke, Frank
    JOURNAL OF HEPATOLOGY, 2021, 75 : S745 - S746
  • [22] A NATIONAL, MULTICENTER, SECONDARY DATA USE STUDY EVALUATING EFFICACY AND RETENTION OF FIRST-LINE BIOLOGIC TREATMENT WITH TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-LIFE SETTING FROM TURKBIO REGISTRY
    Yazici, A.
    Isik, O. Ozdemir
    Dalkilic, E.
    Koca, S. S.
    Pehlivan, Y.
    Senel, S.
    Inanc, N.
    Akar, S.
    Yilmaz, S.
    Gunduz, O. Soysal
    Cefle, A.
    Onen, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1140 - 1141
  • [23] RETENTION RATE AND TREATMENT RESPONSE OF BIOLOGICAL AGENTS IN ADVANCED SPINAL ANKYLOSIS AND BAMBOO SPINE: THE REAL LIFE DATA FROM THE HURBIO REGISTRY
    Farisogullari, B.
    Yardimci, G. K.
    Bolek, E. C.
    Bilgin, E.
    Duran, E.
    Ayan, G.
    Ozsoy, Z.
    Uzun, G. Sandal
    Kilic, L.
    Akdogan, A.
    Bilgen, S. A.
    Karadag, O.
    Kiraz, S.
    Ertenli, A. I.
    Kalyoncu, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 728 - 729
  • [24] Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life
    De Lorenzis, Enrico
    Natalello, Gerlando
    Pellegrino, Greta
    Verardi, Lucrezia
    Batani, Veronica
    Lepri, Gemma
    Stano, Stefano
    Armentano, Giuseppe
    De Pinto, Marco
    Motta, Francesca
    Di Donato, Stefano
    Kakkar, Vishal
    Fiore, Silvia
    Bisconti, Ilaria
    Campochiaro, Corrado
    Cometi, Laura
    Tonutti, Antonio
    Spinella, Amalia
    Truglia, Simona
    Cavalli, Silvia
    De Santis, Maria
    Giuggioli, Dilia
    Del Papa, Nicoletta
    Guiducci, Serena
    Cacciapaglia, Fabio
    De Luca, Giacomo
    Iannone, Fiorenzo
    Ricceri, Valeria
    Matucci Cerinic, Marco
    D'Agostino, Maria Antonietta
    Del Galdo, Francesco
    Bosello, Silvia Laura
    RHEUMATOLOGY, 2024,
  • [25] A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting: results from TURKBIO registry
    Ayten Yazici
    Özlem Özdemir Işık
    Ediz Dalkılıç
    Süleyman Serdar Koca
    Yavuz Pehlivan
    Soner Şenel
    Nevsun Inanc
    Servet Akar
    Sema Yılmaz
    Özgül Soysal Gündüz
    Ayse Cefle
    Ömer Fatih Karakaş
    Fatos Onen
    Scientific Reports, 12
  • [26] A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting: results from TURKBIO registry
    Yazici, Ayten
    Isik, Ozlem Ozdemir
    Dalkilic, Ediz
    Koca, Suleyman Serdar
    Pehlivan, Yavuz
    Senel, Soner
    Inanc, Nevsun
    Akar, Servet
    Yilmaz, Sema
    Gunduz, Ozgul Soysal
    Cefle, Ayse
    Karakas, Omer Fatih
    Onen, Fatos
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [27] First 1-year follow up data from the German NAFLD prospective real-life cohort (FLAG study) show low frequencies of lifestyle changes
    Hofmann, Wolf Peter
    Schattenberg, Jorn M.
    Schubert, Lisa
    Dikopoulos, Nektarios
    Schwenzer, Jeannette
    Muche, Marion
    Heyne, Renate
    Ingiliz, Patrick
    Stein, Kerstin
    Manns, Michael P.
    Zeuzem, Stefan
    Lammert, Frank
    Buggisch, Peter
    JOURNAL OF HEPATOLOGY, 2020, 73 : S170 - S171
  • [28] Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry
    Sara Monti
    Catherine Klersy
    Roberto Gorla
    Piercarlo Sarzi-Puttini
    Fabiola Atzeni
    Raffaele Pellerito
    Enrico Fusaro
    Giuseppe Paolazzi
    Pier Andrea Rocchetta
    Ennio Giulio Favalli
    Antonio Marchesoni
    Roberto Caporali
    Clinical Rheumatology, 2017, 36 : 753 - 761
  • [29] Real-life data on the treatment of biological agents in chronic rhinosinusitis with nasal polyps in the outpatient setting of an ENT practice - our experiences from the first 3 years
    Werminghaus, P.
    Derichs, A.
    Hirschfeld, J.
    Wilm, G.
    ALLERGOLOGIE, 2022, 45 (08) : 613 - 613
  • [30] Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry
    Monti, Sara
    Klersy, Catherine
    Gorla, Roberto
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    Pellerito, Raffaele
    Fusaro, Enrico
    Paolazzi, Giuseppe
    Rocchetta, Pier Andrea
    Favalli, Ennio Giulio
    Marchesoni, Antonio
    Caporali, Roberto
    CLINICAL RHEUMATOLOGY, 2017, 36 (04) : 753 - 761
1234